Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
Verus Capital Partners LLC Purchases 200 Shares of EXACT Sciences Co. (NASDAQ:EXAS)
07:42am, Sunday, 28'th Jun 2020
Verus Capital Partners LLC grew its position in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 40.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities
APG Asset Management N.V. Buys 61,700 Shares of EXACT Sciences Co. (NASDAQ:EXAS)
07:24am, Saturday, 27'th Jun 2020
APG Asset Management N.V. increased its stake in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 45.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund o
Guardant Health's Blood Cancer Test Detects Early-Stage Colon Cancer | The Motley Fool
08:53pm, Monday, 22'nd Jun 2020
Results from a small study will need to be validated by an ongoing study of 10,000 patients.
The Best Stocks To Buy On Down Days
07:12am, Sunday, 21'st Jun 2020
Risk/reward shifts back to neutral, suggesting volatility will continue through the end of the quarter. Healthcare and technology are top sectors to buy on sale
Zacks: Analysts Anticipate EXACT Sciences Co. (NASDAQ:EXAS) Will Announce Earnings of -$0.64 Per Share
06:26am, Saturday, 20'th Jun 2020
Wall Street brokerages expect EXACT Sciences Co. (NASDAQ:EXAS) to post ($0.64) earnings per share (EPS) for the current quarter, Zacks reports. Seven analysts have issued estimates for EXACT Sciences�
Parametric Portfolio Associates LLC Has $5.72 Million Holdings in EXACT Sciences Co. (NASDAQ:EXAS)
05:44am, Saturday, 20'th Jun 2020
Parametric Portfolio Associates LLC lessened its position in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 28.9% in the first quarter, according to its most recent filing with the SEC. The firm owned
Breast cancer genetic test is ensuring better outcomes for Irish patients, oncologist says
12:30am, Saturday, 20'th Jun 2020
State was one of the first countries to adopt the test for early-stage breast cancer patients
MML Investors Services LLC Sells 1,684 Shares of EXACT Sciences Co. (NASDAQ:EXAS)
07:08am, Thursday, 18'th Jun 2020
MML Investors Services LLC lessened its holdings in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 18.5% in the first quarter, according to the company in its most recent 13F filing with the Securities
U.S. Colorectal Cancer Market and Competitive Landscape Assessment 2016-2025 - ResearchAndMarkets.com
12:00am, Wednesday, 17'th Jun 2020
The
Robinhood traders could learn from this growth-stock investor who’s beaten indexes by a wide margin for years
01:28pm, Tuesday, 16'th Jun 2020
Don’t let beginner’s luck fool you into making a painful mistake. John Malooly of Wasatch Ultra Growth explains how to pick winners and prevent your...
Exact Sciences Corp. (NASDAQ: EXAS) today announced the publication of results highlighting the performance of the Oncotype DX Genomic Prostate Score® (GPS™) result in patients with unfavorable int
Breast cancer test is ensuring better outcomes for Irish patients, oncologist says
02:30am, Monday, 15'th Jun 2020
State was one of the first countries to adopt a genetic test for early-stage breast cancer patients
Why Is Exact Sciences (EXAS) Up 2.4% Since Last Earnings Report?
03:31pm, Friday, 05'th Jun 2020
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Edited Transcript of EXAS earnings conference call or presentation 6-May-20 9:00pm GMT
01:49pm, Wednesday, 03'rd Jun 2020
Q1 2020 Exact Sciences Corp Earnings Call
Hedge Funds Cashing Out Of EXACT Sciences Corporation (EXAS)
05:15am, Wednesday, 03'rd Jun 2020
In this article you are going to find out whether hedge funds think EXACT Sciences Corporation (NASDAQ:EXAS) is a good investment right now. We like to check what the smart money thinks first before d
